KCAS Bio, a global provider of harmonized spectral flow cytometry, today announced ongoing developments in its service ...

October 7, 2026) - Palindrome Pharma, a new pharmaceutical company focused on biosimilar medicines, today announced its ...

The Takeda spinout showed that a high dose of solengepras can shorten the periods during which difficult Parkinson’s disease symptoms like involuntary movements and sleepiness.

ArriVent BioPharma’s Phase 3 lung cancer trial was clouded by stronger-than-expected data for patients receiving chemotherapy, prompting analysts to pivot focus to a late-stage test of the tyrosine ...

The Taiwan FDA approved the amended protocol and the lead Taiwan site received IRB approval during September of 2026. The ...

GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced new findings to be presented at the International Consortium on ...

(Nasdaq: VIR) today announced the appointment of David Liu, M.D., Ph.D., as Executive Vice President and Chief Medical ...

MimiVax Inc., a clinical-stage biotechnology company dedicated to the development of innovative cancer immunotherapies, in ...

Clinically relevant reduction in urinary incontinence episodes consistently maintained overtime including in the initial set of patients reaching end of study at 52 weeks Treatment was well tolerated, ...

Tempus (NASDAQ: TEM) today announced an expanded, multi-year collaboration to support the potential commercialization of intismeran autogene (V940/mRNA-4157), a novel, potential first-in-class ...

Poster presentation to feature data highlighting Kalohexis' novel approach to melanocortin agonism and its oral MC3R/MC4R ...

Groundbreaking randomized study will evaluate safety, tolerability, and immune responses to the investigational preventive ...